Hairy Cell Leukemia-HCLin India

Hairy cell leukemia is a rare chronic blood cancer that affects B lymphocytes, treatable with targeted therapy and immunochemotherapy.

Top Oncology hospitals
Experienced Oncology surgeons
Support for international patients
Hairy Cell Leukemia-HCL
Dr. Mohammad Shavez
Written by:Mr. Mohd Ahsan
Medically Reviewed by:Dr. Mohammad Shavez
Updated At7 Oct 2026

Overview

Hairy cell leukemia (HCL) is a slow-growing cancer of the blood and bone marrow.

It causes abnormal B cells with hair-like projections that crowd out healthy cells.

Modern targeted therapies offer excellent long-term control.

Overview And Clinical Background

HCL is a chronic lymphoproliferative disorder that primarily affects middle-aged adults.

It progresses slowly and responds well to therapy.

  • Cell origin:: Derived from mature B lymphocytes.
  • Leads to bone marrow suppression and splenomegaly.
  • Course:: Indolent with long remission periods post-treatment.

Symptoms, Signs And Presentation

Symptoms arise due to bone marrow failure and splenic enlargement.

Infections and fatigue are common.

  • Common symptom:: Persistent fatigue and recurrent infections.
  • Easy bruising or bleeding due to low platelet count.
  • Red flag:: Significant enlargement of the spleen.

Diagnosis Methods And Investigations

Imaging And Laboratory Tests

Diagnosis involves blood smear, bone marrow biopsy, and immunophenotyping.

  • Imaging:: Ultrasound or CT to detect splenomegaly.
  • Lab tests:: CBC showing pancytopenia and abnormal lymphocytes.
  • Flow cytometry confirms the diagnosis by detecting CD11c and CD25 markers.

Treatment Options And Surgical Techniques

Therapy focuses on restoring blood cell levels and controlling symptoms.

Most patients achieve long-term remission.

  • Conservative:: Observation for asymptomatic or mild cases.
  • Minimally invasive options:: Cladribine or pentostatin-based chemotherapy.
  • Targeted therapy such as rituximab for resistant cases.

Recovery, Risks And Prognosis

Most patients achieve remission lasting over a decade.

Relapses are managed effectively with re-treatment.

Why Choose Us

CureU Healthcare’s hematology team offers personalized treatment using advanced immunotherapy and precise monitoring for long-term remission.

Conclusion

Hairy cell leukemia, though rare, has an excellent outlook.

With appropriate care, most patients enjoy normal life expectancy.

Dr. Mohammad Shavez
Medically Reviewed by
Dr. Mohammad Shavez

B.U.M.S, M.D. (NAT) | Reg No. 9153 | Ex. Secretary & Treasurer, N.I.M.A.

Qualified healthcare professional in Unani and Naturopathic medicine with deep expertise in traditional healthcare systems, patient-centered clinical care, and medical content review.

Frequently Asked Questions About Hairy Cell Leukemia-HCL

Hospitals Offering Oncology

BLK-Max Super Speciality Hospital, New Delhi

BLK-Max Super Speciality Hospital, New Delhi

Rajendra Place, New Delhi
650+
Beds
350+
Doctors
Indraprastha Apollo Hospital, New Delhi

Indraprastha Apollo Hospital, New Delhi

Sarita Vihar, New Delhi
700+
Beds
300+
Doctors
Aakash Healthcare Super Speciality Hospital, New Delhi

Aakash Healthcare Super Speciality Hospital, New Delhi

Dwarka Sector 3, New Delhi
230+
Beds
200+
Doctors
Batra Hospital & Medical Research Centre, New Delhi

Batra Hospital & Medical Research Centre, New Delhi

Tughlakabad Institutional Area, New Delhi
500+
Beds
250+
Doctors
Pristyn Care Diyos Hospital, New Delhi

Pristyn Care Diyos Hospital, New Delhi

Safdarjung Enclave, New Delhi
26
Beds
20+
Doctors
Fortis Hospital, Shalimar Bagh, New Delhi

Fortis Hospital, Shalimar Bagh, New Delhi

Shalimar Bagh, New Delhi
375
Beds
Expert Team
Doctors
IBS Institute of Brain and Spine, New Delhi

IBS Institute of Brain and Spine, New Delhi

Lajpat Nagar III, New Delhi
50
Beds
Specialist Team
Doctors
Call Us
Chat now
How can I help you?
CureU Medical Advisor

CureU Medical Advisor

online
🔒 100% Private & Medically ConfidentialCureU AI Care